Heterogeneous induction of microglia M2a phenotype by central administration of interleukin-4

Article English OPEN
Pepe, G.; Calderazzi, G.; De Maglie, M.; Villa, A.; Vegeto, E.;
(2014)
  • Publisher: Springer Nature
  • Journal: Journal of Neuroinflammation, volume 11, issue 1 (issn: 1742-2094, eissn: 1742-2094)
  • Publisher copyright policies & self-archiving
  • Identifiers: pmc: PMC4302702, doi: 10.1186/s12974-014-0211-6
  • Subject: Cellular and Molecular Neuroscience | alternative activation | Settore BIO/14 - Farmacologia | M2 polarization | centrally administered interleukin-4 | microglia | Immunology | alternative activation; centrally administered interleukin-4; M2 polarization; microglia | Research | Neurology

Background Acquisition of the M1 or M2 phenotypes by microglia has been shown to occur during the development of pathological conditions, with M1 activation being widely involved in neurotoxicity in relation with the anatomical localization and the reactivity of subtype... View more
  • References (40)
    40 references, page 1 of 4

    1. Saijo K, Glass CK: Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 2011, 11:775-787.

    2. Colton CA: Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 2009, 4:399-418.

    3. Castano A, Herrera AJ, Cano J, Machado A: Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J Neurochem 1998, 70:1584-1592.

    4. Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT: Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55:453-462.

    5. Qin L, Liu Y, Hong JS, Crews FT: NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration. Glia 2013, 61:855-868.

    6. Neniskyte U, Vilalta A, Brown GC: Tumour necrosis factor alpha-induced neuronal loss is mediated by microglial phagocytosis. FEBS Lett 2014, 588(17):2952-2956.

    7. De Pablos RM, Herrera AJ, Villaran RF, Cano J, Machado A: Dopamine-dependent neurotoxicity of lipopolysaccharide in substantia nigra. FASEB J 2005, 19:407-409.

    8. Vroon A, Drukarch B, Bol JG, Cras P, Breve JJ, Allan SM, Relton JK, Hoogland PV, Van Dam AM: Neuroinflammation in Parkinson's patients and MPTP-treated mice is not restricted to the nigrostriatal system: microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb. Exp Gerontol 2007, 42:762-771.

    9. Hanisch UK: Functional diversity of microglia - how heterogeneous are they to begin with? Front Cell Neurosci 2013, 7:65.

    10. Lawson LJ, Perry VH, Dri P, Gordon S: Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 1990, 39:151-170.

  • Related Organizations (2)
  • Metrics
Share - Bookmark